Cargando…
Genetic screens reveal a central role for heme metabolism in artemisinin susceptibility
Artemisinins have revolutionized the treatment of Plasmodium falciparum malaria; however, resistance threatens to undermine global control efforts. To broadly explore artemisinin susceptibility in apicomplexan parasites, we employ genome-scale CRISPR screens recently developed for Toxoplasma gondii...
Autores principales: | Harding, Clare R., Sidik, Saima M., Petrova, Boryana, Gnädig, Nina F., Okombo, John, Herneisen, Alice L., Ward, Kurt E., Markus, Benedikt M., Boydston, Elizabeth A., Fidock, David A., Lourido, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511413/ https://www.ncbi.nlm.nih.gov/pubmed/32968076 http://dx.doi.org/10.1038/s41467-020-18624-0 |
Ejemplares similares
-
Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies
por: Veiga, M. Isabel, et al.
Publicado: (2016) -
SPARK regulates AGC kinases central to the Toxoplasma gondii asexual cycle
por: Herneisen, Alice L., et al.
Publicado: (2023) -
Plasmodium falciparum resistance to artemisinin-based combination therapies
por: Ward, Kurt E, et al.
Publicado: (2022) -
Mutation in the Plasmodium falciparum BTB/POZ Domain of K13 Protein Confers Artemisinin Resistance
por: Paloque, Lucie, et al.
Publicado: (2022) -
CRISPR-Mediated Transcriptional Repression in Toxoplasma gondii
por: Markus, Benedikt M., et al.
Publicado: (2021)